Interventional pulmonology (IP) is a rapidly evolving subspecialty of pulmonary medicine focused on the diagnosis and treatment of lung disorders using minimally invasive techniques. Over the last few decades, the field has experienced significant growth, driven by advances in technology, a better understanding of lung diseases, and a push toward minimally invasive procedures that improve patient outcomes while reducing risks and recovery time. As we look to the future, interventional pulmonology is poised to play an even more critical role in the management of various respiratory conditions, from lung cancer to chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung diseases (ILDs).